Equity Overview
Price & Market Data
Price: $4.38
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $9,011,144
Volume: 0
Performance Metrics
1 Week: -0.11%
1 Month: -2.99%
3 Months: 7.76%
6 Months: -2.99%
1 Year: 19.86%
YTD: 10.20%
Company Details
Employees: 13
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.